Yannick Doyon

CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systemspublié le 2025-03-20

In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1.publié le 2024-08-23

Accessory-cell-free differentiation of hematopoietic stem and progenitor cells into mature red blood cellspublié le 2023-11

In vivodissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1publié le 2023-09-29

Dairy phages escape CRISPR defence of Streptococcus thermophilus via the anti-CRISPR AcrIIA3.publié le 2023-09-22

MTORas a selectable genomic harbor for CRISPR-engineered CAR-T cell therapypublié le 2023-09-16

Marker-free co-selection for successive rounds of prime editing in human cellspublié le 2022-10-07

Accessory-cell-free differentiation of hematopoietic stem and progenitor cells into mature red blood cellspublié le 2022-09-16

Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci.publié le 2022-06-16

Marker-free coselection for successive rounds of prime editing in human cellspublié le 2021-11-02